1
Clinical Trials associated with RQ-00317076评估RMX1001在健康中国成年受试者中的安全性、耐受性和药代动力学特征的 I 期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of RMX1001 in healthy Chinese adult subjects
主要目的:评估RMX1001在健康中国成年受试者中单次和多次给药剂量递增的安全性、耐受性 次要目的: 1)确定人血浆中的主要代谢产物; 2)评估健康中国成年受试者单次和多次口服不同剂量RMX1001后RMX1001及其主要代谢产物的药代动力学特征;
[Translation] Primary objective: To evaluate the safety and tolerability of single and multiple escalating doses of RMX1001 in healthy Chinese adult subjects Secondary objectives: 1) To determine the major metabolites in human plasma; 2) To evaluate the pharmacokinetic characteristics of RMX1001 and its major metabolites after single and multiple oral administration of different doses of RMX1001 in healthy Chinese adult subjects;
100 Clinical Results associated with RQ-00317076
100 Translational Medicine associated with RQ-00317076
100 Patents (Medical) associated with RQ-00317076
100 Deals associated with RQ-00317076